Natural Compounds as Drugs, Volume II
Springer Basel (Verlag)
978-3-7643-8594-1 (ISBN)
Activation of fungal silent gene clusters: A new avenue to drug discovery.- Total synthesis studies on macrocyclic pipecolic acid natural products: FK506, the antascomicins and rapamycin.- Application of natural product-inspired diversity-oriented synthesis to drug discovery.- Cheminformatics analysis of natural products: Lessons from nature inspiring the design of new drugs.- Chemical-genetic approaches for exploring the mode of action of natural products.- Epothilones as lead structures for new anticancer drugs — pharmacology, fermentation, and structure-activity-relationships.- Histone deacetylase inhibitors from microorganisms: the Astellas experience.- Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720.- Artemisinin — an innovative cornerstone for anti-malaria therapy.
| Erscheint lt. Verlag | 13.3.2008 |
|---|---|
| Reihe/Serie | Progress in Drug Research |
| Zusatzinfo | X, 428 p. 212 illus., 27 illus. in color. |
| Verlagsort | Basel |
| Sprache | englisch |
| Maße | 170 x 250 mm |
| Gewicht | 1270 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Medizin / Pharmazie ► Pharmazie | |
| Naturwissenschaften ► Biologie ► Biochemie | |
| Schlagworte | Bacteria • Cancer • chemical space • Drug • drug discovery • Drug research • enzymes • Fermentation • high throughput screening • lead • natural product • pharmacology • Pharmakologie • receptor • Research • Screening • synthesis |
| ISBN-10 | 3-7643-8594-4 / 3764385944 |
| ISBN-13 | 978-3-7643-8594-1 / 9783764385941 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
